Live Equity Offer - TetraMed Limited
/
TetraMed is an Australian company seeking to become a vertically integrated medicinal cannabis business.
Based in Perth, Western Australia, TetraMed is developing a fully-licensed, modular production facility for medicinal cannabis with an initial capacity of 4 tonnes in Lesotho, a premier region for cannabis cultivation. There, medicinal cannabis will be grown, extracted, processed, and manufactured for global distribution to pharmaceutical companies from the Lesotho operations.
TetraMed is also developing cannabinoid medication in tablet form, providing patients with consistent cannabinoid levels and regulated doses. The first prototype is expected to be developed by the end of 2020.
Closes: Feb 20th
Minimum Investment: $420
Equity Offered: 2-8%
Raising: Up to 1.05M
